TENTORI, LUCIO

TENTORI, LUCIO  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 20 di 149 (tempo di esecuzione: 0.033 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-1986 A miniaturized cell-mediated cytotoxicity assay with human effector mononuclear cells D'Atri, S; Tentori, L; Fuggetta, M; Marini, S; Bonmassar, E Articolo su rivista
1-gen-1989 A novel gamma delta T cell receptor for antigen adds limited diversity to the gamma delta repertoire in adult thymus Marusić Galesić, S; Saito, T; Tentori, L; Zuñiga Pflucker, J; Raulet, D; Allison, J; Kruisbeek, A Articolo su rivista
1-gen-1984 Acquired hemoglobin H disease in a case of refractory anemia with excess of blasts (RAEB) evolving into acute nonlymphoid leukemia Annino, L; Di Giovanni, S; Tentori, L; Cafolla, A; Nanni Costa, M; Salvagnini, M; Angeli, G Articolo su rivista
1-gen-2016 Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P Intervento a convegno
1-gen-1993 Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice Neri, M; Zei, T; Tentori, L; Bonmassar, E; Affabris, E; Iorio, A Articolo su rivista
1-gen-2018 The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. Atzori, Mg; Tentori, L; Ruffini, S; Ceci, C; Bonanno, E; Scimeca, M; Lacal, P; Graziani, G Articolo su rivista
1-gen-2017 The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells Atzori, Mg; Tentori, L; Ruffini, F; Ceci, C; Lisi, L; Bonanno, E; Scimeca, M; Eskilsson, E; Daubon, T; Miletic, H; Ricci Vitiani, L; Pallini, R; Navarra, P; Bjerkvig, R; D'Atri, S; Lacal, Pm; Graziani, G Articolo su rivista
1-gen-2016 Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P Articolo su rivista
1-gen-1995 Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL) Tentori, L; Leonetti, C; Lozupone, F; Bonmassar, E Articolo su rivista
1-gen-2003 Apoptosi e danno cromosomico indotti da bleomicina: effetti del sistema di riparo degli appaiamenti erronei tra le basi e p53 Vernole, P; Levati, L; Tentori, L; D’Atri, S Intervento a convegno
1-gen-2000 Apoptotic and clastogenic effects of methylating agents, alone or combined with poly(ADP-ribose) polymerase inhibitor, in peripheral blood lymphocytes Tentori, L; Vernole, P; Portarena, I; Bonmassar, E; Graziani, G Intervento a convegno
1-gen-2002 Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes Tentori, L; Portarena, I; Vernole, P; Gold, B; Graziani, G Articolo su rivista
1-gen-1990 Are the IL-2 receptors expressed in the murine fetal thymus functional? Zůñiga Pflücker, J; Smith, K; Tentori, L; Pardoll, D; Longo, D; Kruisbeek, A Articolo su rivista
1-feb-2005 Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors. Tentori, L; Leonetti, C; Scarsella, M; Vergati, M; Xu, W; Calvin, D; Morgan, L; Tang, Z; Woznizk, K; Alemu, C; Hoover, R; Lapidus, R; Zhang, J; Graziani, G Articolo su rivista
1-dic-2013 Challenging resistance mechanisms to therapies for metastatic melanoma Tentori, L; Lacal, P; Graziani, G Articolo su rivista
1-gen-1991 Chemical xenogenization: antigenic changes of cancer cells induced by triazene compounds Giuliani, A; D'Atri, S; Franchi, A; Tricarico, M; Tentori, L; Bonmassar, E Articolo su rivista
1-gen-2005 Chemopotentiation by PARP inhibitors in cancer therapy Tentori, L; Graziani, G Articolo su rivista
1-giu-1984 Chemotherapy in hairy cell leukemia. Preliminary results of a nonaggressive regimen Annino, L; Tentori, L; Cameli, G; Angeli, G; Mandelli, F Articolo su rivista
1-gen-2015 Cilengitide down-modulates invasiveness and vasculogenic mimicry of neuropilin-1 expressing melanoma cells through the inhibition of αvβ5 integrin. Ruffini, F; Graziani, G; Levati, L; Tentori, L; D'Atri, S; Lacal, P Articolo su rivista
1-gen-2001 Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells Tentori, L; Portarena, I; Bonmassar, E; Graziani, G Articolo su rivista